Chauhan Ashish 1*, Arora Pradeep 1, Thakur Nisha 2
- Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Govt. of India, Sector-23, Rajnagar, Ghaziabad - 201 002, India
- Abhilashi Institute of Life Sciences, Ner Chock, Mandi, Himachal Pradesh, India
Abstract
Today, about half of all the prescriptions are filled with a generic equivalent of a brand-name drug. Because of the decrease in price, we are now switching from branded drugs to generic drugs and there is a steep inclination towards generic drugs by both patients and health care professionals without compromising the efficacy and safety of the drug. Any drug identified as a generic drug is the bioequivalent of the brandname drug and is typically sold at substantially low cost from the branded one, hence, easily affordable by common man.The present review encompasses the comprehensive portfolio of generic drugs comprising description, evolvement, approval, pharmaco-economics, demand, current scenario and future perspective of the generic drugs. It also throws some light on the position of Indian pharma sector in generics market.
